UNSPSC 51131508: Epoetin alfa

This classification denotes a chemotherapy regimen used to treat non-hodgkins lymphoma with the molecular formula C809H1301N229O240S5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 64FS3BFH5W, more generally known as epoetin alfa. European Medicines Agency schedules epoetin alfa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06575MIG. The term ERYTHROPOIETIN is an International Non-Proprietary Name or INN. Epoetin alfa bears US NLM identifiers UMLS ID C0357126 and NCI Concept Code C2695.

UNSPSC 51131508 Epoetin alfa is a Commodity code for a specific biopharmaceutical product — recombinant human erythropoietin used to treat anemia — yet the single recent state and local opportunity tagged under this code does not involve pharmaceutical procurement at all. Sourcewell, a Minnesota local government unit and service cooperative, posted RFP #061626 on May 12, 2026, soliciting proposals for law enforcement equipment to serve its participating entities and thousands of public agencies across the United States and Canada. The mismatch between the UNSPSC code name and the actual scope of work signals either a cataloging error in the posting or a broader equipment category that does not align with the pharmaceutical product the code nominally describes.

Given this single opportunity and the absence of any supporting context indicating authentic epoetin alfa procurement by state or local bodies, the code shows little actionable recent activity for pharmaceutical suppliers. The law enforcement equipment solicitation, while significant in scale — serving Franklin County, Grant County, Grays Harbor County, Chelan County, Yakima County in Washington, and numerous other jurisdictions nationwide — does not represent the intended market for a biopharmaceutical commodity. Proposals were due June 16, 2026, through the Sourcewell Procurement Portal at https://proportal.sourcewell-mn.gov; vendors seeking clarification were directed to Mari Vielma at rfp@sourcewell-mn.gov or 888-894-1930. Without further evidence of authentic state and local epoetin alfa demand, this code warrants close monitoring only if upstream cataloging corrections surface or if additional healthcare-focused procurement appears.